Minimal injection site pain and high patient satisfaction during treatment with long-acting risperidone

Olanzapine versus Placebo and Haloperidol

1996 • 788 citations

Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo

1997 • 756 citations

Quetiapine in Patients With Schizophrenia

1997 • 487 citations

Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic

2003 • 474 citations

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

2003 • 472 citations

Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?

2002 • 395 citations

Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission

2002 • 349 citations

Guidelines for depot antipsychotic treatment in schizophrenia

1998 • 329 citations

Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

2001 • 296 citations

Treatment of Schizophrenia With Long-Acting Injectable Risperidone

2003 • 291 citations

Intramuscular Preparations of Antipsychotics

2003 • 117 citations

Injections of Depot Antipsychotic Medications in Patients Suffering From Schizophrenia

2001 • 89 citations

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder

2004 • 48 citations